<?xml version="1.0" encoding="UTF-8"?>
<ref id="B13-vaccines-08-00080">
 <label>13.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Clavijo</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>E.M.</given-names>
   </name>
   <name>
    <surname>Hole</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Galic</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Kitching</surname>
    <given-names>P.</given-names>
   </name>
  </person-group>
  <article-title>Development and Use of a Biotinylated 3abc Recombinant Protein in a Solid-Phase Competitive Elisa for the Detection of Antibodies against Foot-and-Mouth Disease Virus</article-title>
  <source>J. Virol. Methods</source>
  <year>2004</year>
  <volume>120</volume>
  <fpage>217</fpage>
  <lpage>227</lpage>
  <pub-id pub-id-type="doi">10.1016/j.jviromet.2004.05.007</pub-id>
  <pub-id pub-id-type="pmid">15288965</pub-id>
 </element-citation>
</ref>
